Logo
Dean Morbeck, our Chief Scientific Officer at Genea, published research exploring how blastocyst development could serve as a reliable indicator of IVF success, potentially reducing the need for lengthy clinical trials and helping accelerate approval of new fertility treatments while maintaining safety standards.